Speaker Profile
M.D., Radiologist, UCSF
Biography
Thomas Hope, MD is a radiologist and nuclear medicine physician. He is the Vice Chair of Clinical Operations and Strategy in the Department of Radiology, and serves as the Director of Molecular Therapy. Dr. Hopes main research focus is on novel imaging agents and therapies, particularly in prostate cancer and neuroendocrine tumors. He lead the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PETMRI, helping lead the development of the clinical PETMRI program. Additionally he leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and PSMA Radioligand Therapy at UCSF.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony:
Luminary Honoree: Hedvig Hricak, Memorial Sloan Kettering
Pioneer Honoree: Michael E. Phelps, UCLA - Keynote: Precision Imaging for Precision Medicine
- Hedvig Hricak, Memorial Sloan Kettering
- Keynote: PET Imaging and Theranostics: Revolutionizing Cancer Detection and Treatment
- Michael E. Phelps, UCLA
- Radiopharmaceuticals for Cancer Therapy (PANEL)
Chair: Wiliam Oh, Yale Caner Center
- Naga Vara Kishore Pillarsetty, Memorial Sloan Kettering
- Jones Nauseef, Convergent Therapeutics
- Thomas Hope, UCSF
- Advancements in Digital Imaging: Enhancing Accuracy in Cancer Diagnostics
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Hedvig Hricak, Memorial Sloan Kettering
- Eliot Siegel, VA Maryland Healthcare System
- Sharmila Majumdar, UCSF
- Wafik El-Deiry, Brown University - Digitalizing Oncology Care: Challenges and Opportunities (PANEL)
Chair: Christian Wolfrum, Siemens Healthineers
- Ashley Smith, Varian
- Marshall Pitz, Manitoba Cancer Care
- Measuring Tumor Aggressiveness: How Nanotechnology is Shaping the Future of Cancer Diagnostics
- Marija Plodinec, ARTIDIS
- Alastair Thompson, Baylor College of Medicine
- Stacey Tinianov, Advocates for Collaborative Education
- Overcoming Health System Barriers and Redefining Oncology Endpoints: The Role of MRD
- Krupa Paranjpe, Sanofi - Unlocking MRD Testing and Beyond: Combining Ultra-High Sensitivity WGS with Low Cost
- Gilad Almogy, Ultima Genomics - Ultra-Rapid NGS Testing: Why Time Matters
- Luca Quagliata, ThermoFisher
- Ibiayi Dagogo-Jack, Massachusetts General Hospital
- PMWC Showcase
- Tuvik Beker, Pangea Biomed
- Navigating Regulatory Hurdles and Reimbursement Pathways for Oncology Innovations
Chair: Sheila Walcoff, Goldbug Strategies
- Wui-Jin Koh, NCCN - Gabriel A. Bien-Willner, Palmetto GBA
- Erin Satterwhite, Optum Specialty Pharmacy
